Boston Scientific (NYSE:BSX) today reported second-quarter sales and earnings that beat the consensus forecast and tightened in sales outlook for the rest of the year.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,